Zazove Associates’s Ligand Pharmaceuticals LGND Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-14,119	Closed	-$1.01M	–	129
2019 Q2	$1.01M	Buy	+14,119	New	+$1.01M	0.09%	74
2019 Q1	–	Hold	0	–	–	–	66